文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.

作者信息

Rosenbaum Lisa

机构信息

Dr. Rosenbaum is a national correspondent for the Journal.

出版信息

N Engl J Med. 2017 Oct 5;377(14):1313-1315. doi: 10.1056/NEJMp1711886. Epub 2017 Sep 13.

DOI:10.1056/NEJMp1711886
PMID:28902570
Abstract
摘要

相似文献

[1]
Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.

N Engl J Med. 2017-10-5

[2]
CAR T-cell therapy effective in B acute lymphoblastic leukaemia.

Lancet Oncol. 2017-6

[3]
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.

J Hematol Oncol. 2016-11-25

[4]
An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells.

Sci China Life Sci. 2016-3-24

[5]
Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis.

Oncotarget. 2015-10-20

[6]
Locally produced CD19 CAR T cells leading to clinical remissions in medullary and extramedullary relapsed acute lymphoblastic leukemia.

Am J Hematol. 2018-9-26

[7]
CD19 directed CARs in acute lymphoblastic leukemia: state of the art and beyond.

Leuk Lymphoma. 2019-5

[8]
The what, when and how of CAR T cell therapy for ALL.

Best Pract Res Clin Haematol. 2017-9

[9]
Predominant cerebral cytokine release syndrome in CD19-directed chimeric antigen receptor-modified T cell therapy.

J Hematol Oncol. 2016-8-15

[10]
CAR T cells for infection, autoimmunity and allotransplantation.

Nat Rev Immunol. 2018-10

引用本文的文献

[1]
Chimeric Antigen Receptor T-cell Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Efficacy, Safety, and Future Directions.

Cureus. 2025-7-31

[2]
CAR T-cell therapy in autoimmune diseases: a promising frontier on the horizon.

Front Immunol. 2025-8-12

[3]
Living Medicines Engineered to Fight: A Comprehensive Review on CAR T-Cell Therapy.

Int J Hematol Oncol Stem Cell Res. 2025-4-1

[4]
Cardiac involvement in systemic sclerosis: A critical review of knowledge gaps and opportunities.

J Scleroderma Relat Disord. 2025-1-20

[5]
Revolutionizing Cancer Treatment: Unveiling the Power of CAR T-cell Therapy.

Curr Pharm Des. 2025

[6]
Use of Eltrombopag to Improve Thrombocytopenia and Tranfusion Requirement in Anti-CD19 CAR-T Cell-Treated Patients.

J Clin Med. 2024-8-28

[7]
The synergistic immunotherapeutic impact of engineered CAR-T cells with PD-1 blockade in lymphomas and solid tumors: a systematic review.

Front Immunol. 2024

[8]
[CAR T-cell therapy in rheumatology-What we know so far?].

Z Rheumatol. 2024-8

[9]
Applications of Intravital Imaging in Cancer Immunotherapy.

Bioengineering (Basel). 2024-3-8

[10]
Building Synthetic Cells─From the Technology Infrastructure to Cellular Entities.

ACS Synth Biol. 2024-4-19

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索